Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q...
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, is included in...
As filed with the Securities and Exchange Commission on July 28, 2009 Registration No. 333- ...
Please note the revised Cautionary Statement paragraph. The corrected release reads: PHASE FORWARD AGREES TO ACQUIRE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.